Dietary Cholesterol Absorption Inhibitor class drugs

4 results

  • ezetimibe and simvastatin

    (Ezetimibe and Simvastatin)
    AvKARE
    Ezetimibe and simvastatin tablets are indicated as adjunct therapy to diet for reducing cholesterol and triglyceride levels in patients with primary or mixed hyperlipidemia, including homozygous familial hypercholesterolemia. They are part of a comprehensive approach to reduce the risk of atherosclerotic vascular disease.
    Medication Details
    Drug Interactions

  • nexlizet

    (Bempedoic Acid and Ezetimibe)
    Esperion Therapeutics, Inc.
    NEXLIZET, a combination of bempedoic acid and ezetimibe, is indicated as an adjunct to diet for reducing LDL-C in adults with primary hyperlipidemia, including HeFH. Bempedoic acid also lowers myocardial infarction and coronary revascularization risk in adults unable to take statins, with or without established cardiovascular disease.
    Medication Details
    Drug Interactions

  • vytorin

    (ezetimibe and simvastatin)
    Organon LLC
    VYTORIN is indicated as an adjunct to diet for reducing elevated LDL cholesterol in adults with primary hyperlipidemia and pediatric patients (10+ years) with heterozygous familial hypercholesterolemia. It also aids in reducing LDL in adults with homozygous familial hypercholesterolemia and lowers cardiovascular risks in high-risk adults.
    Medication Details
    Drug Interactions

  • zetia

    (Ezetimibe)
    Organon LLC
    ZETIA® is indicated for reducing elevated LDL-C in adults with primary hyperlipidemia and HeFH, in pediatric patients (10+ years) with HeFH, adults with mixed hyperlipidemia, and those with HoFH. It also reduces sitosterol and campesterol levels in patients with homozygous familial sitosterolemia.
    Medication Details
    Drug Interactions